Outset Medical, Inc. (OM)
Market Cap | 1.08B |
Revenue (ttm) | 118.29M |
Net Income (ttm) | -170.04M |
Shares Out | 49.23M |
EPS (ttm) | -3.51 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 117,036 |
Open | 22.10 |
Previous Close | 22.32 |
Day's Range | 21.84 - 22.24 |
52-Week Range | 11.41 - 30.55 |
Beta | 1.48 |
Analysts | Strong Buy |
Price Target | 27.60 (+25.28%) |
Earnings Date | Jul 31, 2023 |
About OM
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. [Read more]
Financial Performance
In 2022, Outset Medical's revenue was $115.38 million, an increase of 12.45% compared to the previous year's $102.60 million. Losses were -$162.96 million, 23.5% more than in 2021.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for OM stock is "Strong Buy." The 12-month stock price forecast is $27.6, which is an increase of 25.28% from the latest price.
News

Outset Medical Reports First Quarter 2023 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexi...

Outset Medical to Present at Upcoming Investor Conferences
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...

Outset Medical to Present Research Highlighting Home Hemodialysis Success for Underserved Populations at National Kidney Foundation Spring Clinical Meetings
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis with its Tablo® Hemodialysis System, is prese...

Outset Medical to Report First Quarter 2023 Financial Results on Wednesday, May 3, 2023
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...

Outset Medical to Present at 43rd Annual Cowen Health Care Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...

Outset Medical Reports Fourth Quarter and Full Year 2022 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexi...

Outset Medical to Report Fourth Quarter and Full Year 2022 Financial Results on Monday, February 13, 2023
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,...

Outset Medical Reports Expected Fourth Quarter and Full Year 2022 Revenue, Provides 2023 Revenue and non-GAAP Gross Margin Guidance
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and comple...

Outset Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,...

Outset Medical to Present at the BofA Securities Home Care Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,...

Outset Medical Ranked Number 33 Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced ...

Outset Medical Reports Third Quarter 2022 Financial Results
SAN JOSE, Calif.

Outset Medical Secures Up To $300 Million in Debt Financing
SAN JOSE, Calif.

Outset Medical Presenting Research on Human Factors Testing, Home Dialysis Patient Experience and More During ASN Kidney Week 2022
SAN JOSE, Calif.

Outset Medical to Report Third Quarter 2022 Financial Results Tuesday, November 8, 2022
SAN JOSE, Calif.

OUTSET MEDICAL, INC. (OM) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Outset Medical, Inc. (OM)
Did you lose money on investments in Outset Medical? If so, please visit Outset Medical, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to di...

OM ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 6, 2022 in the Class Action Filed on Behalf of Outset Medical, Inc. Shareholders
NEW YORK , Sept. 6, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM) alleging that the Comp...

OM FINAL DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important September 6 Deadline in Securities Class Action - OM
New York, New York--(Newsfile Corp. - September 6, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) between Se...

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Outset Medical, Inc. with Losses of $500,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 6, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Outset Medical, ...

OM DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors With Losses to Secure Counsel Before Important September 6 Deadline in Securities Class Action - OM
NEW YORK , Sept. 5, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) between September 15, 2020 an...

Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Outset Medical, Inc. (OM) Investors of Class Action and Last Few Hours to Actively Participate
New York, New York--(Newsfile Corp. - September 5, 2022) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset" or "t...

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Outset Medical, Inc. with Losses of $500,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 5, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Outset Medical, ...

OM TUESDAY DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors With Losses to Secure Counsel Before Important September 6 Deadline in Securities Class Action - OM
New York, New York--(Newsfile Corp. - September 3, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) between Sep...

OM SHAREHOLDER ALERT: Jakubowitz Law Reminds Outset Medical Shareholders of a Lead Plaintiff Deadline of September 6, 2022
NEW YORK , Sept. 2, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM).

OM FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors With Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action - OM
New York, New York--(Newsfile Corp. - September 1, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) between Sep...